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The flavoprotein cholesterol oxidase from Brevibacterium
sterolicum (BCO) possesses a narrow channel that links the
active center containing the flavin to the outside solvent. This
channel has been proposed to serve for the access of dioxygen; it
contains at its “bottom” aGlu-Arg pair (Glu-475—Arg-477) that
was found by crystallographic studies to exist in two forms
named “open” and “closed,” which in turnwas suggested to con-
stitute a gate functioning in the control of oxygen access. Most
mutations of residues that flank the channel have minor effects
on theoxygen reactivity.Mutations ofGlu-311, however, cause a
switch in the basic kineticmechanism of the reaction of reduced
BCO with dioxygen; wild-type BCO and most mutants show a
saturation behavior with increasing oxygen concentration,
whereas for Glu-311 mutants a linear dependence is found that
is assumed to reflect a “simple” second order process. This is
taken as support for the assumption that residue Glu-311 finely
tunes the Glu-475—Arg-477 pair, forming a gate that functions
in modulating the access/reactivity of dioxygen.
Bacterial cholesterol oxidase (CO,2 EC 1.1.3.6) is a mono-
meric bifunctional FAD-containing flavoenzyme. It catalyzes
the first step in the pathway of cholesterol degradation in a
number of soil bacteria (1). From amechanistic point of view, it
catalyzes both the dehydrogenation of the C(3)-OH function of
the cholestan system as well as the following isomerization of
the intermediate cholest-5-en-3-one to yield cholest-4-en-3-
one as the final product (Scheme 1) (2, 3). Redox catalysis byCO
can be separated into the two half-reactions, as shown in
Scheme 2. The first half-reaction is the reduction of the flavin
via hydride transfer from the alcohol (the reductive half-reac-
tion), and the second half-reaction is the oxidation of the
reduced flavin by molecular oxygen, the final acceptor (oxida-
tive half-reaction) (4).
CO is a useful biotechnological tool used for the determina-
tion of serum cholesterol levels (for review, see Ref. 2); it pos-
sesses larvicidal activity (5) and has been developed as an insec-
ticide against Coeloptera (5, 6). CO has been discussed as a
factor important for infection by the pathogenic bacterium
Rhodococcus equi (7–9); because this enzymatic activity is
unique to bacteria, it represents a potential target for new
antibiotics.
From a structural point of view, two different types of CO
have been found in nature; COs type I, such as those from Strep-
tomyces sp. SA-COO and R. equi (10) containing non-co-
valently bound FAD, and type II COs (such as Brevibacterium
sterolicumCO (BCO), used in this work), in which the cofactor
is covalently linked to the protein through an 8--N1-histidyl
bond to His-121 (corresponding to His-69 in the mature form
of BCO) (11). The covalent (type II) and non-covalent (type I)
COs differ in many functional properties, such as absorbance
spectra, redox potentials (Em difference100 mV), and kinetic
mechanisms (sequential versus ping-pongmechanism) (12, 13).
The three-dimensional structures of both CO types have been
solved by Vrielink and coworkers (14, 15); they show com-
pletely different tertiary topologies. Type I CO is a member of
the glucose-methanol-choline oxidoreductase family (14),
whereas the type II CO belongs to the vanillyl-alcohol oxidase
subfamily (15), a fold proposed to favor covalent flavinylation.
Despite its basic importance, there are gaps in our knowledge
of the mechanism of oxygen activation by flavoproteins and, in
particular, by COs as well as its regulation and suppression.
COs belonging to both fold classes contain narrow channels
extending from the surface to the buried active sites cavity that
has been proposed to serve in oxygen access (see Fig. 1 for BCO)
(1, 15). In recent yearsmolecular tunnels have emerged as com-
mon structural features among different classes of enzymes. In
both types of COs the tunnel is flanked mainly by hydrophobic
residues (at least in the most external region) and houses a
single string of watermolecules. This finding suggests that oxy-
gen does not diffuse freely into the active site of COs but that
access ismodulated by specific, protein-mediated events. Inter-
estingly, both tunnels appear to be gated by an Arg (in BCO,
type II CO) or an Asn (in Streptomyces sp. SA-COO, type I CO)
residue, albeit operating in opposite fashions. The tunnel is,
thus, closed when the Arg-477 side chain of BCO is positioned
at a hydrogen bonding distance of the flavin ring system (com-
pare the alternative positions of Arg-477 side chain reported in
Fig. 1). In type I CO the tunnel is open whenAsn-485 lies closer
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to the flavin system (1). These differencesmight be at the origin
of the variance in oxygen reactivity of the two types of COs. In
particular, the gating function of the Arg-477 might provide a
rationale for the unusual saturation behavior reflected by the
kinetics of the reaction of reduced BCO with oxygen (4). We
previously proposed that this behavior reflects a reversible con-
version of two enzyme forms possessing different oxygen reac-
tivities (i.e. E-FADred* and E-FADred in Scheme 2); these two
species might, thus, correspond to the “open tunnel” and
“closed tunnel” conformations identified by the structural anal-
ysis (15).
The three-dimensional structure of BCO leads to the identi-
fication of several residues other than Arg-477 that could be
important for oxygen access/reactivity: Ala-204, Ser-307, Gly-
309, Glu-311, Ile-423, and Glu-475 (Fig. 1). The two latter res-
idues in particular adopt two distinct conformations (as Arg-
477), and their movements appear to be coordinated with each
other and with that of Arg-477 (15).
The scope of the present study is to verify the presence and
role of the proposed oxygen tunnel and, in particular, the func-
tion of the amino acid side chains possibly forming the men-
tioned gate. To reach this goal BCO mutants at some of the
positions mentioned above were generated and characterized.
Comprehension of the mechanism of oxygen reactivity in CO
could, thus, shed light on the mechanisms by which flavopro-
tein oxidases govern the access of and the reactivitywithmolec-
ular oxygen, this being a fundamental topic in biochemistry
that still awaits elucidation. It should bementioned that similar
studies on heme proteins have recently produced important
FIGURE 1. Three-dimensional representationof the assumedoxygen channel of BCO (PDB code1I19). The panels depict an open crevice extending from
the surface to the active site cavity in which the flavinmoiety of the FAD cofactor (yellow) is located. In the so-called “open gate” (left) and “closed gate” (right)
conformations the side chains of Ile-423, Glu-475, and Arg-477 adopt different conformations. The latter two are represented with space-filling models. Some
of the residues shown were subjected to mutagenesis.
SCHEME 1. Reaction catalyzed by cholesterol oxidase.
SCHEME 2. Kinetic mechanism of BCO, adapted from Pollegioni et al. (4).
Both the oxidized and reduced forms of BCO are competent in the isomeriza-
tion reaction (23). kconv and kconv are steps in which an “interconversion” of
species with a different reactivity with dioxygen occurs. kisom stands for the
rate of the isomerization reaction depicted in Scheme 1.
Oxygen Reactivity of Cholesterol Oxidase
SEPTEMBER 5, 2008•VOLUME 283•NUMBER 36 JOURNAL OF BIOLOGICAL CHEMISTRY 24739
 at UNIV. O
F INSUBRIA on Septem
ber 1, 2008 
w
w
w
.jbc.org
D
ow
nloaded from
 
insights (16–20) that serve as a guideline and reference for the
present study.
EXPERIMENTAL PROCEDURES
Reagents and DNA Manipulation—Restriction enzymes
were from New England Biolabs. Enzymatic DNA modifica-
tions were carried out according to themanufacturer’s instruc-
tions and as described in Sambrook et al. (21). Plasmid DNA
extraction and purification were performed using FlexiPrepTM
and SephaglasTM BandPrep kits from GE Healthcare. Thesit
(polyethylene glycol 400 dodecyl ether), cholesterol, and cho-
lest-5-en-3-one were from Fluka. All chromatographic col-
umns were from GE Healthcare.
Cloning, Mutagenesis, Enzyme Expression, and Purification—
Asynthetic gene coding for the BCOmature formwas obtained
fromMedigenomix GmbH (Martinsried, Germany). It is based
on the amino acid sequence reported in the three-dimensional
structure, PDB accession code 1I19 (15). The coding nucleotide
sequence was optimized for expression in Escherichia coli. The
synthetic gene was cloned into the expression plasmid
pET24b() (Novagen) using NdeI/XhoI restriction sites.
Mutagenesis reactions were performed using QuikChange
site-directed mutagenesis kit (Stratagene). Recombinant
BL21(DE3)pLysS E. coli cells were grown in 2LB or TBmedia
(Sigma) supplemented with the appropriate antibiotics (chlor-
amphenicol 34 mg/liter and kanamycin 30 mg/liter, final con-
centration) at 37 °C up to late stationary phase (absorbance at
600 nm,1.5–2). Induction was done with isopropyl 1-thio--
D-galactopyranoside (1 mM final concentration), and cells were
collected after 14–26 h of growth at 25 °C. Wild-type and
mutant BCOs were expressed in E. coli cells in fairly good
amounts (about 5 mg of pure enzyme/g cell; 15 mg pure
enzyme/liter culture). Recombinant BCOs (all containing a
C-terminal His tag) were purified using Ni2 affinity chroma-
tography (HiTrap Chelating HP columns equilibrated with 50
mM potassium phosphate, pH 7.5, 1 M NaCl). Elution of bound
enzyme was performed with a linear gradient of imidazole
(0–0.5 M) in 50 mM potassium phosphate, pH 7.5, 0.5 M NaCl;
recombinant BCOs eluted at about 0.075–0.1 M imidazole.
Imidazole was removed by extensive dialysis against 100 mM
potassium phosphate buffer, pH 7.5.
Isolation of COPreparationsDevoid of Non-covalently Bound
FAD—Recombinant enzyme preparations devoid of non-co-
valently bound FAD were obtained by exploiting the higher
thermolability of the BCO containing non-covalent FAD com-
pared with the covalent form. The substrate cholesterol was
also present as the reduced form of BCO containing covalently
linked FAD was found to be selectively stabilized. A 1-ml sam-
ple of BCO containing 0.5 mM cholesterol was incubated for 3
min at 45 °C. The resulting turbid preparation was centrifuged
for 2 min at 12,000 rpm in an Eppendorf tube to yield a clear,
yellow supernatant and awhite pellet (the non-covalent formof
BCO) that was discarded. The supernatant was ultrafiltered
through a BIOMAX 5000 membrane (Millipore) to10% that
of the original volume. This was diluted with 0.1 M potassium
phosphate, pH 7.5, and the filtration procedure was repeated.
The filtrate contains unmodified FAD, whereas the fraction in
the upper chamber consists of BCO containing covalently
bound FAD. The ratio of the quantities of FAD present in free
form (filtrate) versus that bound to BCO (retained fraction)
reflects the ratio of non-covalently versus covalently FAD-
bound BCO forms. The procedure gives BCO preparations
with covalently bound FAD at a purity95% and yields ranging
from 20 to 90% that of the starting material, depending on the
BCO mutant.
Spectroscopic Experiments—All spectral experiments were
carried out at 15 °C in 100 mM potassium phosphate at pH 7.5.
Extinction coefficients of the enzyme forms were determined
by complete denaturation of the enzyme in 6.4 M guanidinium-
HCl, 20 mM potassium phosphate at pH 7.5 assuming that the
extinction coefficient of fully denatured enzyme-bound FAD is
the same as that of the free FAD (11,300M1 cm1) (22). For the
study of the interaction with sulfite, the reagent (sodium salt)
was prepared just before use as a 2 M stock solution in 100 mM
potassium phosphate, pH 7.5. Aliquots were then added to
enzyme (10 M), and the changes in absorbance at 450 nm
were recorded; this reflects formation of theN(5)-sulfite adduct
(12). The rate of complex dissociation (koff) was determined
spectrophotometrically by following the decay of the complex
in a sample that was freed of excess sulfite by gel filtration on a
Sephadex G25 column (PD10 column) (12).
Enzymatic Activity and Kinetic Measurements—Kinetic
experiments were performed at 25 °C and pH 7.5 in 100 mM
potassium phosphate in the presence of 1% Thesit and 1% pro-
pan-2-ol (dehydrogenation reaction) or 10% propan-2-ol
(isomerization reaction) (v/v final concentrations). Steady-
state kinetic measurements at constant O2 concentration (0.25
mM, air saturation at 25 °C) were performed by monitoring
H2O2 production using the horseradish peroxidase assay (4
g/ml, 0.3 mg/ml o-dianisidine, 440  13 mM1 cm1) as
previously described (4, 12, 13). The isomerization reaction
(Scheme 1) was followed spectrophotometrically at 240 nm
(240  15.5 mM1 cm1). Rapid kinetic measurements were
performed as described previously (4, 23) using a BioLogic
SFM-300 stopped-flow instrument equipped with a 1-cm path
length and interfaced to a J&M diode-array detector. The
steady-state kinetics for the reactions at saturating O2 and cho-
lesterol concentrations was assessed based on the enzyme-
monitored turnover (EMTN) method of Gibson et al. (24) in
which the enzymewasmixedwith an equal volume of substrate
solution (either aerobic or anaerobic to yield a final O2 concen-
tration 0.125 mM) in the stopped-flow instrument. The trace
at 446–453 nm (depending on the enzyme form) detects the
conversion of oxidized into reduced enzyme forms. For EMTN
experiments traces were analyzed according to Gibson et al.
(24) and using KaleidaGraphTM (Synergy Software). The
kinetic traces are treated as records of the rate of catalysis as a
continuous function of oxygen concentration. For details about
anaerobiosis of enzyme (10–12M) and substrate (in the 0.05–
0.75 mM range) solutions, see Pollegioni et al. (4) and Lim et al.
(23). For the investigation of the oxidative half-reaction
enzymeswere reducedwith a 3-fold excess of cholesterol under
anaerobic conditions and then reacted with buffer solutions
equilibrated with different N2/O2mixtures (4). Rapid reactions
were routinely monitored by acquiring spectra in the
Oxygen Reactivity of Cholesterol Oxidase
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190–700-nm wavelength range with an acquisition time of 0.8
ms/spectrum and resolution of 1 nm (4, 23).
Generation of Reduced Enzyme Forms—The reduction of
BCO enzymes was achieved routinely by photoreduction in the
presence of EDTA and 5-deaza-riboflavin essentially as
described in Gadda et al. (12) andMassey and Hemmerich (25)
and in 100 mM potassium phosphate buffer, pH 7.5, at 25 °C.
Cuvettes with the protein solution were in a water bath at
10–15 °C and at 15 cm from a 150-W quartz halogen light
source. The cuvette was removed at time intervals to record
absorption spectra, and this was continued until completion of
the process.
Determination of Redox Potentials—For this purpose the
xanthine/xanthine oxidase method was employed as reported
earlier for wild-type and H69A BCOs (12, 13). The redox indi-
cators used are listed in Table 2.
RESULTS
General Properties of BCO Mutants—Among the BCO vari-
ants studied, only mutants at position Glu-311 and Glu-475
were obtained as preparations containing almost exclusively
covalently bound FAD (Table 1). Recombinant wild-type BCO
as well as most other mutants was obtained as a mixture of
enzyme forms containing covalently as well as non-covalently
bound FAD (Table 1). The two forms of BCO were identified
based on the differences in their absorption spectra (13), and
their ratio was estimated as described under “Experimental
Procedures.” This value is about 1:1 in the case of wild-type
and A204C and R477A/K BCO mutants, whereas with
G309A/C and I423L/V mutants the covalent form is more
prominent (60–80%, Table 1). For these BCO proteins the
use of different expression conditions (variation of cultiva-
tion media, growth temperatures, and time of recovery after
isopropyl 1-thio--D-galactopyranoside addition) did not
result in the expression of a unique (either covalently or
non-covalently bound FAD) protein. The biochemical char-
acterization of all BCO variants was carried out using prepa-
rations containing essentially only covalent FAD (95%),
obtained as described under “Experimental Procedures.” The
absence of substantial quantities of the apoprotein form was
assessed based on the A278 nm/A450 nm ratio that was14.5.
In a general context spectral effects in flavoproteins reflect
modifications of the microenvironment at the active site. The
spectra of recombinant and commercial wild-type BCOs are
identical. This provides a basis for comparison with previous
studies done with the latter (12). In general, mutations induce a
minor hypochromic effect on the main absorption band in the
visible (Fig. 2). This is depicted for the Glu-311 mutants in Fig.
2A, where also a 7–10-nm shift of its maximum to longer wave-
lengths is evident. In the case of Arg-477 mutants, and partic-
ularly of R477A BCO, the spectral shape (Fig. 2B) is modified to
reflect a more hydrophobic environment (26). Minor alter-
ations of the absorption spectrum were also observed for the
other BCOmutants (Figs. 2, C and D, and Table 1); this is con-
sistent with the assumption that the modifications at the active
center induce only minor structural effects. Noteworthy, the
near- and far-UV CD spectra of all BCO mutants (not shown)
are similar to that of wild-type BCO, thus confirming the
absence of main conformational changes.
The reduced forms of BCOs were obtained by anaerobic
reduction with cholesterol. Wild-type BCO and the A204C,
G309C, E311D/Q, E475D/Q, and R477K BCO mutants are
completely reduced within a few seconds by a 2–5molar excess
of cholesterol. G309A and I423L/I423V mutants were also
promptly reduced but only after the addition of about a 20-fold
molar excess of cholesterol. The obtained spectra are charac-
teristic of reduced flavoproteins, with minor differences for
individual mutants (not shown), again suggesting the absence
of major differences in the interactions of reduced flavin and
environment. On the other hand, for the E311L BCO mutant
only an50% flavin reduction (estimated by comparison with
the fully reduced form of the E311D/Q BCO mutants) was
observed using an excess up to 270-fold of cholesterol and after
several hours of anaerobic incubation (Table 1). The same
extent of flavin reduction (50%)was observedwith the R477A
TABLE 1
Properties of wild-type BCO andmutants upon isolation and purification
The extent of covalently bound FAD present in purified BCOpreparations was estimated as described under “Experimental Procedures.” The extent of flavin reduction was
estimated from the relative decrease of the absorbance at the maximum in the visible region that occurs upon anaerobic addition of cholesterol (2–5 molar excess or as
specified in parentheses). The semiquinone form (R, red; B, blue) was produced by photoreduction. ND, not determined.
Enzyme
form
Content of
covalent FAD /max
Flavin reduction by cholesterol Formation of
(red/blue) semiquinoneMaximal extent Rate (cholesterol:enzyme ratio)
% mM1 cm1/nm % % of total
Wild-type
Commerciala 100 13.4/448 100 Fast R 70
Recombinant 40–60 13.4/449 100 Fast R 75
A204C 40–60 11.9/445 100 Fast ND
G309A 60–70 11.4/447 100 Fast (20:1) ND
G309C 70–90 12.0/445 100 Fast ND
E311D 100 11.2/455 100 Fast R 90
E311Q 100 10.7/458 100 Fast R 100
E311L 100 11.2/453 50 Slow (270:1) R 100
I423L 85 11.8/449 100 Fast (20:1) ND
I423V 65 11.6/449 100 Fast (20:1) ND
E475D 100 11.6/455 100 Fast R 100
E475Q 100 12.1/453 100 Fast R 100
R477A 50 12.6/447 50 Extremely slow (300:1) B Rb
R477K 60 12.5/448 100 Fast R B 80
a Data are from Gadda et al. (12).
bMixture of oxidized and red blue semiquinone, not quantifiable.
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BCOmutant after incubation for 1 week under anaerobic con-
ditions. Noteworthy, these latter two mutants show negligible
activity in both the dehydrogenation and the isomerization
reactions (see below).
Anaerobic photoreduction of wild-type and E311D/Q and
E475D/Q COs leads to the formation of the kinetically stabi-
lized, red anion semiquinone form as previously observed for
commercial BCO (12). This is the species predicted for the fla-
vin dehydrogenase/oxidase family members (27). The amount
of semiquinone produced by recombinant wild-type BCO is
similar to that observed with the commercial BCO (13) (Table
1). A similar extent of flavin photoreduction is also observed
for the R477K BCO. However, in this case a weak, long-
wavelength absorption band extending up to 600 nm was
observed, and this effect was much more pronounced with
R477A BCO. This is consistent with formation of the flavin
neutral blue semiquinone and suggests a pK increase of the
radical species, which can be attributed to the differences in
charge and that affects the stabilization of the negatively
charged anionic semiquinone (see also “Discussion” and
Table 1).
Reaction with Sulfite—The ability to bind sulfite to form
covalent N(5) adducts is a characteristic of flavoprotein oxi-
dases, and it yields information on the redox potential of a given
enzyme (27). This approach was used in the present work to
provide criteria for a differentiation of effects resulting from
alterations of redox potentials as opposed to steric factors; per-
tinent data are listed in Table 2. The reaction of commercial
wild-typeBCOwith sulfitewas previously found to be a second-
order process (12). With the E311Q/L and E475Q BCO
mutants, attainment of equilibrium is sufficiently rapid to allow
an estimation of the Kd value based on results of titrations with
sulfite. In all other cases the rate constant for the step of sulfite
binding (kon) was obtained from the slope of linear plot of the
rates of adduct formation at different sulfite concentrations
estimated from the decrease in absorbance at450 nm. For the
determination of the rate of dissociation (koff), the adduct
was purified from excess sulfite by rapid gel-permeation
chromatography, and its decay was followed by the absorb-
ance increase at450 nm corresponding to the formation of
oxidized enzyme. The most significant effect on the Kd val-
ues (Table 2) was observed for the removal of the positive
charge at position 477.
Redox Potentials—These parameters were estimated for wild
type (as a reference) and for selected BCO mutants deemed to
be relevant in the present context, i.e. for the cases where mod-
ification of charges are expected. The data are listed in Table 2.
The redox potential of recombinant BCO was measured using
indigo tetrasulfonate and cresyl violet. The midpoint potential
(Em) found was 96 mV, the same as that determined earlier
using commercial BCO (12). A salient point is that the imple-
mented mutations have comparatively small effects on Em
(Table 2). These range from an increase of the midpoint poten-
tials by 20 mV in the case of mutations of Glu-311 and Glu-
475 to a decrease of40mV for the R477Kmutant (Table 2). In
contrast to this, a more pronounced effect of themutations was
observed on the separation between the single one-electron
transfer potentials (E1, E2). In those cases where mutations do
not induce a change of charge, the separation of E1 and E2 is
somewhat lower (see e.g. R477K and E311D BCOs). When a
charge is removed (E311Q and E475Q), the separation
increases substantially (Table 2).
Steady-state Kinetics—The kinetic parameters for wild-type
and mutants of BCO under steady-state conditions were
assessed using two complementary methods: those obtained
with the classical o-dianisidine/peroxidase assay at 0.25 mMO2
concentration (air saturation, 25 °C, 1% Thesit, 1% 2-propanol)
FIGURE 2. Absorption spectra of recombinant wild-type BCO and of
selectedmutants. The spectra are of the oxidized state of the enzymes, and
for comparison, the trace ofwild-type BCO is shown in all panels. The concen-
trations of the enzymes were 10–12 M in 100 mM potassium phosphate
buffer, pH7.5, andat 15 °C; the spectrawerenormalized to reflect their extinc-
tion coefficients.
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and saturating cholesterol concentrations that are defined as
“apparent” and indicated with quotation marks and the data
obtained with the EMTN method (initial O2 concentration 
0.125 or 0.25 mM, 25 °C) (24) that are calculated for both satu-
rating O2 and cholesterol concentrations. Mutations at posi-
tion 204, 309, and 423 have aminor effect (3-fold) on kcat and
Km for O2-dependent turnover and for the isomerization reac-
tion of BCO (Table 3). Most significant effects are instead
observed for the Glu-475 BCO mutants (Table 3); however,
because a decrease in kcat is accompanied in all cases by a
decrease in Km, these changes do not modify (2-fold) the
apparent kcat/Km ratio. A large effect was instead observed
for substitution of residues Glu-311 and Arg-477. In partic-
ular, the dehydrogenation reaction decreases about 70-fold
when the negative charge at position 311 is removed
(E311Q), a change that also affects kcat of the isomerization
reaction (Table 3). The most drastic effect is observed with
E311L and R477A BCOs for which both oxidation and
isomerization activities are substantially lowered (Table 3).
As indicated by the ratio of the corresponding kcat values (last
column of Table 3), the mutations have different effects on the
isomerization and dehydrogenation reactions; this was partic-
ularly prominent in the cases of Arg-477, where even the most
conservative modification (R477K) most significantly affected
the oxidative reaction. In this context is should be reiterated
that for all BCO variants tested, the isomerization reaction was
not rate-limiting (Table 3).
The kinetic mechanism of the reaction of commercial wild-
type BCO with cholesterol as substrate was previously investi-
gated by a combination of steady-state and pre-steady-state
measurements; it is consistent with a ping-pongmechanism (4)
(Scheme 2). Steady-state measurements based on the EMTN
method (see “Experimental Procedures”) have been performed
for recombinant wild-type and mutants of BCO that showed
the most significant changes in the previous kinetic measure-
ments (Fig. 3). It should be recalled that in this type of experi-
TABLE 2
Parameters of the interaction of wild-type BCO andmutants with sulfite and redox potentials of selected mutants
Sulfite complex formation experiments were carried out at 15 °C in 100 mM potassium phosphate buffer, pH 7.5, at 15 °C. The rates were determined spectroscopically by
following the absorbance decrease/increase at450 nm corresponding to sulfite binding/dissociation. Determination of redox potentials as described under “Experimental
Procedures” and using the dyes listed.
Enzyme form kon koff Kda Em (E1, E2) Redox dyeb
mM1 min1 min1 M mV
Wild-type
Commercialc 0.37 0.05 140 101c IDS, CV
Recombinant 0.33	 0.02 0.016	 0.002 48 96 (47,147) ITS, CV
A204C 0.080	 0.005 0.038	 0.005 475
G309A 0.081	 0.002 0.025	 0.003 309
G309C 0.078	 0.004 0.024	 0.004 308
E311D 3.4	 0.2 0.022	 0.002 6.5 76 (39,113) ITS, IDS
E311Q 33	 1 0.052	 0.008 1.6/17	 4 84 (13,157) ITS, CV
E311L 7.4	 0.4 0.022	 0.001 3/42	 10
I423L 0.096	 0.011 0.01	 0.001 104
I423V 0.133	 0.004 0.012	 0.001 90
E475D 2.21	 0.06 0.03	 0.003 14
E475Q Fast (50) 0.28	 0.02 16	 4 87 (18,155) ITS, CV
R477A 0.0019	 0.0001 0.021	 0.001 11000
R477K 0.044	 0.002 0.048	 0.006 1100 138 (low separation) IDS
aKd values obtained by determination of either kon and koff (Kd koff/kon) or, for E311Q/L and E475Q BCOs, estimated from static titration experiments based on end points
of absorbance changes (data are in italics).
b ITS, indigo tetrasulfonate (Em43.3 mV); IDS, indigo disulfonate (Em124 mV); CV, cresyl violet (Em176 mV).
c Data are from Ref. 12.
TABLE 3
Apparent steady-state kinetics parameters for reactions of wild-type BCO andmutants
The parameters for cholesterol dehydrogenation (oxidation) reaction determined at constant oxygen concentrations are apparent. Conditions: 100 mM potassium
phosphate buffer, pH 7.5, 1% propan-2-ol, and 1% Thesit at 25 °C, assuming an oxygen concentration of 0.25 mM (air saturation). Measurements of the isomerization
reaction were done in the same buffer containing 10% propan-2-ol, 1% Thesit, at 25 °C by following the cholest-4-en-3-one formation at 240 nm. ND, not determined.
Enzyme form
Dehydrogenation (oxidation) reaction
(substrate, cholesterol)
Isomerization reaction
(substrate, cholest-5-en-3-one) Ratiokcat,isomerization/kcat,dehydrogenationkcat Km,chol kcat/Km,chol kcat Km,chol-en kcat/Km,chol-en
s1 mM mM1 s1 s1 mM mM1 s1
Wild-type
Commercial 34	 1 0.2	 0.03 170 300	 50 0.6	 0.1 500 8.8
Recombinant 54	 4 0.31	 0.02 175 410	 70 0.5	 0.1 820 7.6
A204C 25	 1 0.31	 0.02 80 350	 5 1.0	 0.1 350 14
G309A 38	 1 0.32	 0.01 120 190	 12 0.45	 0.05 420 5
G309C 37	 1 0.21	 0.02 175 270	 6 0.55	 0.03 490 7.3
E311D 9.3	 0.5 0.14	 0.03 65 15	 1 0.05	 0.01 300 1.6
E311Q 0.82	 0.02 0.26	 0.05 3.2 14	 2 0.3	 0.02 47 17
E311L 0.0014	 0.0001 0.32	 0.01 0.004 0.11	 0.002 1.4	 0.1 0.08 80
I423L 51	 4 0.23	 0.06 220 320	 30 0.6	 0.1 535 6.3
I423V 28	 1 0.17	 0.01 165 320	 30 0.8	 0.1 400 11
E475D 6.5	 0.2 0.05	 0.01 130 31	 1 0.04	 0.01 775 4.8
E475Q 25	 6 0.10	 0.04 250 52	 1 0.17	 0.04 305 2.1
R477A 
0.001 ND ND 0.6	 0.02 0.013	 0.001 45 600
R477Ka 1.3	 0.4 0.67	 0.20 1.9 69	 0.5 0.45	 0.02 155 53
a Average fromMichaelis-Menten and double reciprocal plots.
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ment (24) the percentage of oxidized enzyme specie is depicted
as a function of time where the area “below the experimental
trace” reflects the quantity of O2 present in the system. From
this it is evident that the activity (inversely proportional to the
time required for depletion of the oxygen present in the system)
is significantly decreased for all mutants, the largest effect
occurring with E311Q and R477K BCOs. Lineweaver-Burk
plots (i.e. the plot reporting 1/kcat,app versus 1/[O2]) of the
kinetic data obtained according to Gibson et al. (24) yields par-
allel lines for all BCO mutants (not shown), consistent with a
ping-pong mechanism as found with commercial wild-type
BCO (4). The largest decrease in kcat values were still observed
for mutants at positions Glu-311 and Arg-477, especially when
the charge was removed (Table 4). Km values for cholesterol
were higher for all mutants compared with wild-type BCO. In
contrast, the Km,O2 value for all BCOmutants tested was lower
than for wild-type BCO and was affected significantly in the
R477K mutant (Table 4). Comparison of the data in Tables 3
and 4 evidences a good correspondence between the apparent
kinetic parameters (k) and those determined at infinite oxygen
and cholesterol concentrations. The only exception is E475D
BCO where a 3-fold difference is encountered. Differences of
this parameter up to 4-fold were reported earlier for COs from
varying sources (12) depending on the type of assay used. This
was assumed to result from different susceptibilities of the var-
ious enzyme forms from the assay conditions (12).
Reaction of Reduced Cholesterol Oxidases with Dioxygen—
Theoxidation of reduced commercial wild-type BCObyO2 can
be represented by a combination of steps (Scheme 2). As dis-
cussed earlier, free reduced enzyme species are assumed to
interconvert via step kconv/kconv yielding a form that can react
with O2 via k4 to yield oxidized enzyme and H2O2 (4). The
oxidative half-reaction of position 423 mutants was not inves-
tigated in detail as their kinetic properties closely resemble
those of wild-type BCO (see Table 3). Those of E311L and
R477A mutants could not be studied due to their low activity
and because of difficulties in obtaining the reduced forms (see
Tables 1 and 3). Primary traces from stopped-flow experiments
obtained bymixing the reduced enzymewith buffer solutions at
varying O2 concentrations (increase in absorbance at 455 nm
versus time, Fig. 4) are best fitted by a biphasic (two-exponen-
tial) model in the case of wild-type, A204C, A309A/C, E311D,
and E475D/Q BCOs. On the other hand, traces for E311Q and
R477K mutants are best fitted using monophasic algorithms.
Where a biphasic model is used, the second, slower phase
accounts formaximally 5–10% of the total absorbance changes;
this extentwas found to depend also on the enzymepreparation
FIGURE 3. Enzyme-monitored turnover experiments according to the
method of Gibson et al. (24).Wild-type andmutant BCOs (20–25M) in 100
mM potassium phosphate buffer, pH 7.5, 1% propan-2-ol, and 1% Thesit at
25 °Cwere reacted in the stopped-flow instrumentwith 1mMcholesterol and
125Moxygen (panels A andB) or 1mMcholesterol and250Moxygen (panel
C) (all final concentrations). The time course of the reactionwasmonitored at
450 nm, and from the extinction coefficients of the oxidized versus reduced
species (determined in separate experiments) the percentage of oxidized
enzyme was normalized on the ordinate.
TABLE 4
Steady-state kinetics parameters for the dehydrogenation
(oxidation) reaction of recombinant wild-type andmutants of BCO at
infinite oxygen and cholesterol concentration (EMTNmethod)
Measurements were in 100 mM potassium phosphate buffer, pH 7.5, 1% propan-2-
ol, and 1% Thesit at 25 °C.
Enzyme form 01 kcat s O2 Km,cholesterol Km, O2
s1 M s M s mM mM
Wild-type
Commerciala 19.2 10.9 7.3 0.21 0.14
Recombinant 52	 4 5.8 4.2 0.3	 0.1 0.22	 0.02
E311D 10	 1 90 6 0.9	 0.1 0.06	 0.01
E311Q 1.1	 0.1 640 64 0.7	 0.1 0.07	 0.01
E475D 21	 3 52 9.5 1.1	 0.1 0.20	 0.03
E475Q 29	 6 38 3.1 1.1	 0.2 0.09	 0.01
R477Kb 1.4	 0.3 1470 14 2.1	 0.04 0.02	 0.001
a Data from Ref. 4.
b Average fromMichaelis-Menten and double reciprocal plots.
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used. The corresponding rate does not depend on oxygen con-
centration and has values around 5 s1 in all cases. This phase
was not used for kinetic considerations, also since its nature is
still unclear and might be related to some heterogeneity in the
protein. As shown in Fig. 4, the time required to oxidize the
reduced enzyme(s) varies depending on the specific mutation;
it is significantly longer for E311Q and R477K BCO. The pres-
ence of superoxide dismutase (SOD, 20 units/ml) has no effect
on the rate of flavin reoxidation of both wild-type and E311Q
BCOs (species with a fast and a very slow rate, respectively).
This is in keeping with the absence of basic changes in the
mechanism of reoxidation of BCO by dioxygen induced by the
mutations.
As reported earlier (4, 28), the observed rates for the main
phase of oxidation (kobs) of reduced wild-type BCO shows a
hyperbolic saturation with increasing O2 concentration. A
similar behavior is also observed for recombinant wild-type
BCO as depicted in Fig. 5A. This behavior has been proposed
to result from the presence of a kinetic situation as repre-
sented in Scheme 2, steps kconv/kconv and k4 (4). This leads
to Equation 1,
kobs kconv  k4  O2/kconv k4  O2 (Eq. 1)
according to which the apparent rate increases with the sub-
strate concentration until saturation is reached (28, 29).
As shown in Table 4, the kconv values are substantially
unmodified (2-fold) with A204C, G309A/C, and E475Q BCO
mutants, whereas a most significant decrease is evident for
E475D and R477K BCOs (see Fig. 5B for the latter). On the
other hand, the k4/kconv ratio was affected by these substitu-
tions to a lesser extent. Most importantly, kobs values deter-
mined for both E311D/Q BCOs show a linear dependence on
O2 concentration (Fig. 5, A and B, respectively), compatible
with a second order reaction (pseudo-first order process) (29).
This behaviorwould resultwhen the preceding interconversion
(Scheme 2) was absent or much faster than oxidation. Interest-
FIGURE 4. Time course of the reaction of reduced wild-type BCO and
mutantswithdioxygen.Enzymes (12M) in100mMpotassiumphosphate
buffer, pH 7.5, 1% propan-2-ol, and 1% Thesit at 25 °C were reduced by a 3–5
molar excess of cholesterol andwere then reacted in the stopped-flow instru-
ment with 125M oxygen in the same buffer. The reaction wasmonitored as
described under “Experimental Procedures.” The time courses (data points, )
are obtained fromdiode array spectra extracting the time dependence of the
absorbance values at specific wavelengths, e.g. at450 nm. The scale of the
ordinate is defined as in the legend to Fig. 3. The lines through the data points
are fits obtained using monoexponential (curves 3 and 4) or biexponential
algorithms (curves 1 and 2).
FIGURE5.Dependenceofkobs, the rate constants estimated for the reaction
ofreducedenzymeswithdioxygenfromtheconcentrationofthe latter.The
data points for rate constants were obtained as described under “Experimental
Procedures” and inFig. 4 andare theaverageof5–6 singleexperiments.PanelsA
andB, thecurves forwild-typeandE475KBCOsare fromfitsbasedonEquation1.
The straight lines through the data points (E311D and E311Q BCOmutants) are
fromlinear fits.PanelC, double reciprocalplotof thedata forwild-typeandR477K
BCO; the fit through the data points is based on the reciprocal of the equation
above. The values of kconv (1/y intercept) and k4/kconv (x intercept) have been
estimatedfromsuchplots (seetext).Whereerrorbarsarenotvisiblethedatascatter
is smaller than thesizeof the symbols.
Oxygen Reactivity of Cholesterol Oxidase
SEPTEMBER 5, 2008•VOLUME 283•NUMBER 36 JOURNAL OF BIOLOGICAL CHEMISTRY 24745
 at UNIV. O
F INSUBRIA on Septem
ber 1, 2008 
w
w
w
.jbc.org
D
ow
nloaded from
 
ingly, the elimination of a negative charge at position 311
(E311Q BCOmutant) led to an10-fold slower oxidation rate
constant k4 compared with wild-type BCO (Table 5, Fig. 5).
DISCUSSION
A major purpose of the present work is a comparison of the
reactivity of wild-type BCO with dioxygen with that of various
mutants with the substitutions of amino acid residues men-
tioned in the Introduction. A precondition for this is thatmuta-
tions do not alter significantly (other) basic properties of the
enzymes to be compared. Based on inspection of general spec-
tral properties and specifically of the CD spectra (not shown), it
appears that the introduced amino acid substitutions do not
affect the folding pattern of BCO. On the other hand and in the
context of the process of folding, an unexpected observation
was stumbled upon; there is a dependence of the extent of for-
mation of the covalent linkage between His-121 and the flavin
(flavinylation) from mutations that are at substantial distance
(up to 21 Å in the case of the residue Gly-309) from the point of
linkage itself (C8 atom of FAD). This suggests that a variety of
distant mutations can affect the local conformations necessary
for flavinylation. This topic, although of general interest (30),
will not be addressed here and will be the subject of future
studies. A drawback resulting from thementioned heterogene-
ity of flavinylation is that it leads to the production of mixtures
of purified protein forms (flavinylated and non-flavinylated),
the reactivity of which differ substantially (13). Of basic impor-
tance for the present study was, thus, the ability to generate
BCO proteins that are close to homogeneity with respect to
flavinylation. A95%purity was achieved by selective denatur-
ation and exploiting the higher thermolability of not flaviny-
lated BCOs (Table 1).
The effects induced by mutagenesis on the spectra of the
oxidized proteins, on the formation/stability of the anionic
(red) or neutral (blue) semiquinone forms, on the stability of the
sulfite adducts, and on the redox potentials (Table 1 and 2) is
taken as to reflect the modification of charges and of dielectric
properties. Obviously these could also be factors to consider in
comparing rates of oxygen reactivity (see below). It should be
recalled that the redox potential of the flavin cofactor is affected
not only by charges/dipoles in its immediate vicinity but also by
the “global charge” in its further environment as demonstrated
by Swenson andZhou (31, 32) for flavodoxins. The data listed in
Table 2 for sulfite binding toBCOmutants show thatmutations
lead maximally to an 10-fold increase and an 20-fold
decrease in Kd, with the exception of R477A where the elimi-
nation of a neutralizing charge probably has an important
effect. In agreement with this, the effects of mutations on the
redox potentials of BCO are rather small and within 40 mV of
the Em value for wild-type BCO (Table 2).
Inspection of Table 3 reveals that the E311L and R477A
mutations have substantial effects on the kinetic parameters for
turnover with cholesterol as substrate and on the isomerization
reaction. This is taken as suggesting that in these specific cases
the catalytic machinery is disrupted, possibly for steric (E311L)
and charge balance (R477A) reasons. Interestingly, the Km for
cholesterol is affected to a lesser extent. The finding of consid-
erable activity with E311Q indicates that the carboxylate of
Glu-311 is not essential for catalysis but probably assists in the
correct positioning of Arg-477. This is in contrast with the con-
clusions inferred from comparison of the three-dimensional
structure of covalent and non-covalent COs (1, 15). A positive
charge at position 477, however, appears to be crucial since its
removal lowers activity by5 orders of magnitude. This effect
is likely to be the combination of several factors, the one on the
redox potential, as reflected by a 100-fold higher Kd for forma-
tion of the sulfite adduct probably being important (Table 2).
In general, the mutations introduced in BCO affect the kcat
for substrate dehydrogenationmore than the rate of isomeriza-
tion. Instead, with the Glu-475 mutants the opposite is
observed (lower kcat,isomerization/kcat,dehydrogenation, Table 3).
The isomerization of cholest-5-en-3-one to the 4-en-3-one has
been proposed by Coulombe et al. (15) to be catalyzed by Glu-
475. Because the isomerization activity is lowered only7-fold
for the E475Qmutant, it is unlikely that Glu-475 is an essential
residue intimately involved in this step. On the other hand,
from the data listed in Table 3 it is apparent that Glu-311 plays
TABLE 5
Rate constants for the reaction of reduced wild-type BCO andmutants with dioxygen
Measurements were in 100mM potassium phosphate buffer, pH 7.5, 1% propan-2-ol, and 1% Thesit (final concentrations in the cuvette) at 25 °C and as detailed in the text.
k4 was obtained from experiments such as in Fig. 4 and subsequent double reciprocal plots as in Fig. 5C. According to Refs. 14, 28, and 29, in the double reciprocal plot (1/kobs
vs. 1/O2 concentration), the y axis intercept yields 1/kconv whereas the x axis intercept corresponds to k4/k-conv. For examples of “saturation” vs. “linear” behavior, see Fig. 5.
kconv and k-conv refer to assumed conversions between two reduced enzyme forms before the oxygen reaction, as outlined in Scheme 2. ND, not determined. k4 1/O2 is
derived from EMTN experiments (Table 4) as detailed (4).
Enzyme
form
Pattern of
kobs vs O2 plot kconv k4/k-conv (1/Kd)
k4
From secondary
plots
( 1/O2) from EMTN data
(kcat/Km, O2)
s1 mM1 mM1s1
Wild type
Commerciala Saturation 170	 30 4.8 140
Recombinant Saturation 240	 70 2.3 240
A204C Saturation 270	 40 1.5 ND
G309A Saturation 200	 35 4.3 ND
G309C Saturation 110	 19 5.2 ND
E311D Linear 71	 6 170
E311Q Linear 6.3	 0.2 16
E475D Saturation 63	 7 3.5 105
E475Q Saturation 130	 15 5.1 325
R477K Saturation 15.3	 1.4 6.9 70
a Data are from Ref. 4.
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a predominant role as its mutation has an1000-fold effect on
dehydrogenation activity. A supportive role of, or a combina-
tion with Arg-477 is probable. The latter is within H-bonding
distance from the steroidOH-group and forms aH-bond to the
carboxylic group of Glu-311 in the gate open conformation
(15).
Turning to the oxygen reactivity of reduced wild-type and
mutants of BCO (Table 5), it appears that in the cases where a
saturation behavior of kobs versusO2 concentration occurs, the
observed rates are significantly altered only for R477K BCO
(see Fig. 5).On the other hand, the data in Fig. 5 andTable 5 also
highlight the most prominent result of the present study,
namely the finding that mutation of Glu-311 leads to a basic
change in the mechanism by which O2 reacts with reduced
BCO. Thus, removal of Glu-311 converts the “saturation
behavior” of the rate of reoxidation versusO2 concentration to
a linear dependence that might reflect an apparent second
order reaction. Saturation behavior is specific of this oxidase
and is assumed to result from an equilibrium between two
reduced enzyme forms where one preferentially reacts with
oxygen (4, 28). A linear dependence is common of most fla-
voproteins oxidases and reflects an apparent second order reac-
tion (29). It should be emphasized that the effects on the rates of
oxygen reactivity of the Glu-311 mutants are most likely not
attributable to alterations of the redox potentials since the
minor modification (Table 2) cannot account for the observed
effects. This also agrees with the observation that a reduction of
the rates of oxygen reactivity is induced by the E311Q and the
R477K mutations, whereas the corresponding Em values move
in opposite directions (Table 2). The present interpretations are
in keeping with the earlier assumption (4, 23) that the kinetic
behavior of BCO with O2 is not due to “artifacts” resulting e.g.
from the presence of micelles in the system. To the contrary, it
lends support to the mechanism that emerged from the three-
dimensional structure of BCO (15) in which the pair Glu-475—
Arg-477 was found in different conformations named gate
open/gate closed as shown in Fig. 1. That the switch from sat-
uration behavior (possibly related to an interconversion situa-
tion such as depicted in Scheme 2) to an apparent bimolecular
mechanism (Fig. 5) occurs with the mutation of Glu-311 is
somewhat surprising. It suggests that the Glu-475—Arg-477
gate is finely tuned byGlu-311 and that an additional separation
by 2–3 Å (the equivalent of a -CH2 segment) of the -COO
charge from the positive one of Arg-477 is sufficient to alter the
mode of interaction. Interestingly, the longer chain of lysine
present in R477K BCO mutant does not appear to disrupt the
interaction, although the kconv rate constant appears to
be reduced, this resulting in a lower reactivity with oxygen.
These effects are compatible with the decrease of the rate of
interconversion of the reduced enzyme forms (closed form ver-
sus open form, see Scheme 2), although othermechanisms can-
not be excluded.
A hypothesis concerning the role and function of the dis-
cussed channel and gate can be formulated; a saturation mech-
anism might serve in a better utilization of oxygen at low con-
centrations (sequestration), whereas the gating could be
involved in regulating the reactivity of the reduced enzyme-
product complex. The present results should be viewed also in
the context of recent studies dealing with the mode of access/
diffusion ofO2 in various proteins containing a hememoiety. In
several cases specific channels have been identified, and the
kinetics of the diffusion process has been studied (16–20). It,
thus, appears that the presence of specific channels that might
be regulated is a common theme in enzymes that act on
dioxygen.
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